Article ID Journal Published Year Pages File Type
9215687 Medical Journal Armed Forces India 2005 5 Pages PDF
Abstract
Our study recommends that p53 should be used as regular immunohistochemical marker while grading the dysplasia of ulcerative colitis, especially in indefinite cases as it brings objectivity in grading. Our study also came to a conclusion that use of bcl-2 for grading dysplasia of ulcerative colitis is not of any significant help.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Dentistry, Oral Surgery and Medicine
Preview
Study of p53 and bcl-2 Oncoproteins in Ulcerative Colitis with Dysplasia
Authors
, , , , ,